The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Role of prostaglandin E 2 -dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
Open accessAbstract
Overexpression of human cyclooxygenase 2 (COX-2) in the mammary glands of transgenic mice induces tissue-specific tumorigenic transformation. However, the molecular mechanisms involved are not yet defined. Here we show that COX-2 expressed in the epithelial cell compartment regulates angiogenesis in the stromal tissues of the mammary gland. Microvessel density increased before visible tumor growth and exponentially during tumor progression. Inhibition of prostanoid synthesis with indomethacin strongly decreased microvessel density and inhibited tumor progression. Up-regulation of angiogenic regulatory genes in COX-2 transgenic mammary tissue was also potently inhibited by indomethacin treatment, suggesting that prostanoids released from COX-2-expressing mammary epithelial cells induce angiogenesis. G protein-coupled receptors for the major product, prostaglandin E 2 (PGE 2 ) EP 1-4 , are expressed during mammary gland development, and EP 1,2,4 receptors were up-regulated in tumor tissue. PGE 2 stimulated the expression angiogenic regulatory genes in mammary tumor cells isolated from COX-2 transgenic mice. Such cells are tumorigenic in nude mice; however, treatment with Celecoxib, a COX-2-specific inhibitor, reduced tumor growth and microvessel density. These results define COX-2-derived PGE 2 as a potent inducer of angiogenic switch during mammary cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Self-citationColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Self-citationPrognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ristimaki, A. P., Sivula, A., Lundin, J. E., Lundin, M., Salminen, T. M., Haglund, C. H., Joensuu, H., & Isola, J. J. (2002) · PubMed · Cited by 780
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Self-citationChemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris, R. E., Alshafie, G. A., Abou‐Issa, H., & Seibert, K. (2000) · PubMed · Cited by 540
Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao, C. V., Rivenson, A., Simi, B., Zang, E. A., Kelloff, G. V., Steele, V. E., & Reddy, B. S. (1995) · PubMed · Cited by 402
Nonsteroidal Antiinflammatory Drugs and Breast Cancer
Harris, R. E., Namboodiri, K. K., & Farrar, W. B. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00017 · Cited by 345
Lazard, D., Sastre, X., Frid, M. G., Glukhova, M. A., Thiery, J. P., & Koteliansky, V. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.999 · Cited by 334
Seno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., & Taketo, M. M. (2002) · PubMed · Cited by 327
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
Müller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., & Fürstenberger, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192323799 · Cited by 240
How Tumors Make Bad Blood Vessels and Stroma
Dvorak, H. F. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64309-x · Cited by 230
Howe, L. R., Subbaramaiah, K., Patel, J. A., Masferrer, J. L., Deora, A., Hudis, C. A., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M. C., et al. (2002) · PubMed · Cited by 219
Cyclooxygenase-1 and -2 isoenzymes
Hla, T., Bishop-Bailey, D., Liu, C. H., Schaefers, H. J., & Trifan, O. C. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00152-6 · Cited by 219
Self-citationThurston, G., Baluk, P., Hirata, A., & McDonald, D. M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.6.h2547 · Cited by 159
Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia
Brem, S. S., Gullino, P. M., & Medina, D. (1977) · Science · doi:10.1126/science.402692 · Cited by 156
Peebles, R. S., Hashimoto, K., Morrow, J. D., Dworski, R., Collins, R. D., Hashimoto, Y., Christman, J. W., Kang, K.-H., Jarzecka, K., Furlong, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.2106025 · Cited by 116
Silver, R. M., Edwin, S. S., Trautman, M. S., Simmons, D. L., Branch, D. W., Dudley, D. J., & Mitchell, M. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117719 · Cited by 111
Richards, J. A., & Brueggemeier, R. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021475 · Cited by 104
Hovey, R. C., Goldhar, A. S., Baffi, J., & Vonderhaar, B. K. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.5.0635 · Cited by 81
Lala, P. K., Al-Mutter, N., & Orucevic, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<371::aid-ijc12>3.0.co;2-g · Cited by 66
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011338 · Cited by 772
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Metadata
- Authors
- Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-12-19
- Volume
- 101
- Issue
- 2
- Pages
- 591-596
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1970050679
- Cited by
- 361
- References
- 31
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.